- Home
- SONN vs XXII Comparison
SONN vs XXII Comparison
Compare SONN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- XXII
- Stock Information
- Founded
- SONN N/A
- XXII 1998
- Country
- SONN United States
- XXII United States
- Employees
- SONN N/A
- XXII N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- XXII Medicinal Chemicals and Botanical Products
- Sector
- SONN Health Care
- XXII Health Care
- Exchange
- SONN Nasdaq
- XXII Nasdaq
- Market Cap
- SONN 4.6M
- XXII 2.1M
- IPO Year
- SONN N/A
- XXII N/A
- Fundamental
- Price
- SONN $1.29
- XXII $1.25
- Analyst Decision
- SONN Strong Buy
- XXII
- Analyst Count
- SONN 2
- XXII 0
- Target Price
- SONN $38.00
- XXII N/A
- AVG Volume (30 Days)
- SONN 31.6K
- XXII 801.9K
- Earning Date
- SONN 05-16-2025
- XXII 05-13-2025
- Dividend Yield
- SONN N/A
- XXII N/A
- EPS Growth
- SONN N/A
- XXII N/A
- EPS
- SONN N/A
- XXII N/A
- Revenue
- SONN $1,000,000.00
- XXII $24,382,000.00
- Revenue This Year
- SONN $5,376.22
- XXII $19.23
- Revenue Next Year
- SONN N/A
- XXII $81.05
- P/E Ratio
- SONN N/A
- XXII N/A
- Revenue Growth
- SONN 674.14
- XXII N/A
- 52 Week Low
- SONN $1.10
- XXII $0.70
- 52 Week High
- SONN $16.00
- XXII $226.80
- Technical
- Relative Strength Index (RSI)
- SONN 45.29
- XXII 54.27
- Support Level
- SONN $1.30
- XXII $0.75
- Resistance Level
- SONN $1.37
- XXII $1.42
- Average True Range (ATR)
- SONN 0.10
- XXII 0.14
- MACD
- SONN -0.01
- XXII 0.11
- Stochastic Oscillator
- SONN 22.58
- XXII 76.32
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.